Cargando…
Pyruvate dose response studies targeting the vital signs following hemorrhagic shock
OBJECTIVES: To determine the optimal effective dose of sodium pyruvate in maintaining the vital signs following hemorrhagic shock (HS) in rats. MATERIALS AND METHODS: Anesthetized, male Sprague-Dawley rats underwent computer-controlled HS for 30 minute followed by fluid resuscitation with either hyp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520030/ https://www.ncbi.nlm.nih.gov/pubmed/26229300 http://dx.doi.org/10.4103/0974-2700.160729 |
_version_ | 1782383600768909312 |
---|---|
author | Sharma, Pushpa Vyacheslav, Makler Carissa, Chalut Vanessa, Rodriguez Bodo, Mike |
author_facet | Sharma, Pushpa Vyacheslav, Makler Carissa, Chalut Vanessa, Rodriguez Bodo, Mike |
author_sort | Sharma, Pushpa |
collection | PubMed |
description | OBJECTIVES: To determine the optimal effective dose of sodium pyruvate in maintaining the vital signs following hemorrhagic shock (HS) in rats. MATERIALS AND METHODS: Anesthetized, male Sprague-Dawley rats underwent computer-controlled HS for 30 minute followed by fluid resuscitation with either hypertonic saline, or sodium pyruvate solutions of 0.5 M, 1.0 M, 2.0 M, and 4.0 M at a rate of 5ml/kg/h (60 minute) and subsequent blood infusion (60 minute). The results were compared with sham and non- resuscitated groups. The animals were continuously monitored for mean arterial pressure, systolic and diastolic pressure, heart rate, pulse pressure, temperature, shock index and Kerdo index (KI). RESULTS: The Sham group remained stable throughout the experiment. Non-resuscitated HS animals did not survive for the entire experiment due to non-viable vital signs and poor shock and KI. All fluids were effective in normalizing the vital signs when shed blood was used adjunctively. Sodium pyruvate 2.0 M was most effective, and 4.0 M solution was least effective in improving the vital signs after HS. CONCLUSIONS: Future studies should be directed to use 2.0 M sodium pyruvate adjuvant for resuscitation on multiorgan failure and survival rate in HS. |
format | Online Article Text |
id | pubmed-4520030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45200302015-07-30 Pyruvate dose response studies targeting the vital signs following hemorrhagic shock Sharma, Pushpa Vyacheslav, Makler Carissa, Chalut Vanessa, Rodriguez Bodo, Mike J Emerg Trauma Shock Original Article OBJECTIVES: To determine the optimal effective dose of sodium pyruvate in maintaining the vital signs following hemorrhagic shock (HS) in rats. MATERIALS AND METHODS: Anesthetized, male Sprague-Dawley rats underwent computer-controlled HS for 30 minute followed by fluid resuscitation with either hypertonic saline, or sodium pyruvate solutions of 0.5 M, 1.0 M, 2.0 M, and 4.0 M at a rate of 5ml/kg/h (60 minute) and subsequent blood infusion (60 minute). The results were compared with sham and non- resuscitated groups. The animals were continuously monitored for mean arterial pressure, systolic and diastolic pressure, heart rate, pulse pressure, temperature, shock index and Kerdo index (KI). RESULTS: The Sham group remained stable throughout the experiment. Non-resuscitated HS animals did not survive for the entire experiment due to non-viable vital signs and poor shock and KI. All fluids were effective in normalizing the vital signs when shed blood was used adjunctively. Sodium pyruvate 2.0 M was most effective, and 4.0 M solution was least effective in improving the vital signs after HS. CONCLUSIONS: Future studies should be directed to use 2.0 M sodium pyruvate adjuvant for resuscitation on multiorgan failure and survival rate in HS. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4520030/ /pubmed/26229300 http://dx.doi.org/10.4103/0974-2700.160729 Text en Copyright: © Journal of Emergencies, Trauma, and Shock http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Sharma, Pushpa Vyacheslav, Makler Carissa, Chalut Vanessa, Rodriguez Bodo, Mike Pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
title | Pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
title_full | Pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
title_fullStr | Pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
title_full_unstemmed | Pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
title_short | Pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
title_sort | pyruvate dose response studies targeting the vital signs following hemorrhagic shock |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520030/ https://www.ncbi.nlm.nih.gov/pubmed/26229300 http://dx.doi.org/10.4103/0974-2700.160729 |
work_keys_str_mv | AT sharmapushpa pyruvatedoseresponsestudiestargetingthevitalsignsfollowinghemorrhagicshock AT vyacheslavmakler pyruvatedoseresponsestudiestargetingthevitalsignsfollowinghemorrhagicshock AT carissachalut pyruvatedoseresponsestudiestargetingthevitalsignsfollowinghemorrhagicshock AT vanessarodriguez pyruvatedoseresponsestudiestargetingthevitalsignsfollowinghemorrhagicshock AT bodomike pyruvatedoseresponsestudiestargetingthevitalsignsfollowinghemorrhagicshock |